« FDA Warns Consumers Not to Eat Veggie Booty Snack Food | Main | FDA Approvals - CUBICIN Approved for S. aureus Bloodstream Infections in South Korea »

FDA Permits Restricted Use of Zelnorm for Qualifying Patients The


FDA Permits Restricted Use of Zelnorm for Qualifying Patients
The U.S. Food and Drug Administration announced that it is permitting the restricted use of Zelnorm (tegaserod maleate) under a treatment investigational new drug (IND) protocol to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in women younger than 55 who meet specific guidelines.
 

©2006 FDA-News.com. All rights reserved.